AR026371A1 - Nueva formulacion, uso y metodo - Google Patents
Nueva formulacion, uso y metodoInfo
- Publication number
- AR026371A1 AR026371A1 ARP000105838A ARP000105838A AR026371A1 AR 026371 A1 AR026371 A1 AR 026371A1 AR P000105838 A ARP000105838 A AR P000105838A AR P000105838 A ARP000105838 A AR P000105838A AR 026371 A1 AR026371 A1 AR 026371A1
- Authority
- AR
- Argentina
- Prior art keywords
- conditions
- prodrugs
- metabolites
- optionally comprises
- comprises salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9904750A SE9904750D0 (sv) | 1999-12-23 | 1999-12-23 | New formulation, use and method |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026371A1 true AR026371A1 (es) | 2003-02-05 |
Family
ID=20418276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000105838A AR026371A1 (es) | 1999-12-23 | 2000-11-06 | Nueva formulacion, uso y metodo |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1244431A1 (fr) |
AR (1) | AR026371A1 (fr) |
AU (1) | AU1068101A (fr) |
MY (1) | MY133485A (fr) |
PE (1) | PE20011024A1 (fr) |
SE (1) | SE9904750D0 (fr) |
WO (1) | WO2001047503A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1629843A3 (fr) * | 1999-07-01 | 2006-03-15 | Pharmacia & Upjohn Company LLC | Reboxétine pour traiter le syndrome de fatigue chronique |
DK1459750T3 (da) | 1999-07-01 | 2005-08-15 | Pharmacia & Upjohn Co Llc | (S,S)-rebexetin til behandling af fibromyalgi og andre somatoforme lidelser |
US20030082225A1 (en) * | 2001-10-19 | 2003-05-01 | Mason Paul Arthur | Sterile, breathable patch for treating wound pain |
EP2338873A1 (fr) | 2009-12-22 | 2011-06-29 | Gmeiner, Peter | Nouveaux dérivés d'aminotétraline |
TWI754702B (zh) | 2016-12-28 | 2022-02-11 | 德商Ucb製藥有限公司 | (氮雜)吲哚-和苯並呋喃-3-磺醯胺類 |
DE102017127433A1 (de) | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | TTS auf Basis von klebenden Weichmacher-Polymer-Matrices |
US20190381056A1 (en) | 2018-06-17 | 2019-12-19 | Axsome Therapeutics, Inc. | Compositions for delivery of reboxetine |
TW202016088A (zh) | 2018-06-19 | 2020-05-01 | 德商Ucb製藥有限公司 | 吡啶基及吡基-(氮)吲哚磺醯胺 |
EP3584244A1 (fr) | 2018-06-20 | 2019-12-25 | UCB Pharma GmbH | Indolsulfonamides alkoxypyridinyl substitués |
US20200147093A1 (en) | 2018-10-15 | 2020-05-14 | Axsome Therapeutics, Inc. | Use of esreboxetine to treat nervous system disorders such as fibromyalgia |
CN113993845A (zh) | 2019-06-17 | 2022-01-28 | 优时比制药有限公司 | 作为治疗cns障碍例如多发性硬化的gpr17调节剂的n-(苯基)-吲哚-3-磺酰胺衍生物和相关化合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5155198A (en) * | 1997-08-28 | 1999-03-22 | Robert Murdock | Method and composition for transdermal administration of pharmacologic agent |
-
1999
- 1999-12-23 SE SE9904750A patent/SE9904750D0/xx unknown
-
2000
- 2000-10-12 WO PCT/SE2000/001972 patent/WO2001047503A1/fr not_active Application Discontinuation
- 2000-10-12 EP EP00971947A patent/EP1244431A1/fr not_active Withdrawn
- 2000-10-12 AU AU10681/01A patent/AU1068101A/en not_active Abandoned
- 2000-11-06 AR ARP000105838A patent/AR026371A1/es unknown
- 2000-11-15 PE PE2000001219A patent/PE20011024A1/es not_active Application Discontinuation
- 2000-12-21 MY MYPI20006094A patent/MY133485A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1244431A1 (fr) | 2002-10-02 |
SE9904750D0 (sv) | 1999-12-23 |
AU1068101A (en) | 2001-07-09 |
MY133485A (en) | 2007-11-30 |
PE20011024A1 (es) | 2001-10-03 |
WO2001047503A1 (fr) | 2001-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5190662A1 (es) | Inhibidores altamente selectivos de la recaptacion de la norepinefrina y metodos de uso de los mismos | |
AR026371A1 (es) | Nueva formulacion, uso y metodo | |
CU20150180A7 (es) | Piridin-2 que contienen il-4-derivados sustituidos de 1-diazino fenilo útiles como ligandos de dopamina | |
NO20055208L (no) | 4-(2-fenylsulfanyl-fenyl)-piperidinderivater som serotonin-reopptaksinhibitorer | |
AR077975A1 (es) | Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina | |
CO6640335A2 (es) | Tratamiento terapéutico para síndrome metabólico, diabetes de tipo 2, obesidad o prediabetes | |
AR062841A1 (es) | Tratamiento del dolor, diabetes, y trastornos del metabolismo de los lipidos | |
NI201500066A (fr) | ||
UY29613A1 (es) | Compuestos quimicos vi | |
NI200700032A (es) | Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas | |
EA200801488A1 (ru) | Замещенные фенетиламины, обладающие серотонинергической и/или норэпинефринергической активностью | |
NI201100117A (es) | Antagonistas de 4 -- azetidinil - 1 - heteroaril - ciclohexanol del ccr2. | |
NO20061440L (no) | Metode fo fremstilling av tiotropiumsalter og farmasoytiske formuleringer inneholdende samme. | |
NO20075153L (no) | Terapeutisk anvendelse av nefopam og analoger derav | |
Krystal et al. | Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments | |
PE20040924A1 (es) | Bromhidrato de escitalopram y un metodo para su preparacion | |
BRPI0408320A (pt) | composto, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio afetivo | |
MXPA05010678A (es) | Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de recaptacion de serotonina. | |
DE60312874D1 (de) | Kombinationstherapie mit verwendung eines serotonin-wiederaufnahmehemmers | |
BRPI0407569A (pt) | uso de s-10-hidróxi-10, 11-diidro-carbamazepina para o tratamento de ansiendade e distúrbios bipolares | |
NO20085172L (no) | 3-(1h-indol-3-yl)indan-1-ylaminderivater for behandlingen av depresjon og angst | |
ATE423772T1 (de) | Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin | |
EA201070736A1 (ru) | 4-[2,3-дифтор-6-(2-фтор-4-метилфенилсульфанил)фенил]пиперидин | |
AR039723A1 (es) | Terapia de combinacion en donde se utiliza un inhibidor de recaptacion de serotonina | |
AR048134A1 (es) | La combinacion de un inhibidor de la recaptacion de serotonina y un antagonista del receptor de la histamina 3, el agonista inverso o el agonista parcial |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |